-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, H1+NfRB3pUNtKESM7J9psBeLz23eUoYCUhoI2Qf2JihTLagY8MpVC6sRxHRoD3fB i4XVMG2AC3q4AuUpHSN1Tg== 0001266375-06-000043.txt : 20060307 0001266375-06-000043.hdr.sgml : 20060307 20060307153548 ACCESSION NUMBER: 0001266375-06-000043 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060227 FILED AS OF DATE: 20060307 DATE AS OF CHANGE: 20060307 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000835887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133379479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9147892800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHEINBERG DAVID A CENTRAL INDEX KEY: 0001250316 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23143 FILM NUMBER: 06670078 MAIL ADDRESS: STREET 1: 325 CENTRAL PARK W STREET 2: APT 38 CITY: NEW YORK STATE: NY ZIP: 10025 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2006-02-27 0 0000835887 PROGENICS PHARMACEUTICALS INC PGNX 0001250316 SCHEINBERG DAVID A 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2006-02-27 4 M 0 5000 4 A 29181 D Common Stock 2006-02-27 4 S 0 5000 30.02 D 24181 D Non-Qualified Stock Option (right to buy) 4 2006-02-27 4 M 0 5000 0 D 2000-12-31 2007-04-01 Common Stock 5000 58000 D Sale under a 10b5-1 Plan, which was established in accordance with the policies and procedures of the Issuer, approved by its Board of Directors The Reporting Person is exercising options under this grant in pre-established increments under and in accordance with provisions of a previously established Plan of Sale under Rule 10b5-1, which was established in accordance with the policies and procedures of the Issuer, approved by its Board of Directors. David A. Scheinberg 2006-03-07 -----END PRIVACY-ENHANCED MESSAGE-----